Day: April 22, 2022

Dear Madam, Sir, Please find hereafter our press release regarding a disclosure of transparency notification. We remain at your entire disposal for any further information. Sincerely yours,Attachments2022 04 22 – Déclaration de transparence (rectificatif)2022 04 22 – Transparency notification (amendment)2022 04 22 – Transparantiekennisgeving (rectificatie)

Figure 1: Plan view of the SKG MRE with historical drilling and new drilling completed in 2021 showing (highlighted in red) hole location of assay results included in this News Release. Note that all the reported holes are within unclassified resource area, therefore confirming the potential to upgrade and significantly expand the existing MRE for Skaergaard.Figure 2: Section A-A´ looking north showing distribution of PdEQ mineralisation beneath the glacier. Boundaries of mineralised horizons are preliminary interpretations and will be adjusted for the updated MRE:Figure 3: Section B-B´ looking east showing distribution of PdEQ near surface mineralisation in the NE plateau located north of the Glacier. Boundaries of mineralised horizons are preliminary interpretations and will be adjusted for the updated MRE:Figure 4: Section...

Kiruna April 22, 2022 The annual report for 2021 is now published and available, in Swedish, on Copperstone’s website www.copperstone.se. For further information, please contact CEO Anna Tyni on +46 (0) 70 – 561 46 11 E-mail: anna.tyni@copperstone.se or info@copperstone.se or www.copperstone.se ABOUT COPPERSTONE Copperstone Resources AB is a company now scaling up to become a modern and responsibly producing mining company through the reopening of the Viscaria mine in Kiruna, Sweden. Thedeposit’s high copper grade assessed mineral resources, geographical location and growing team of experts provides good opportunities to become a key supplier of quality and responsiblyproduced copper – a metal that plays a critical role in Sweden’s and Europe’s climate change towards an electrified society. In addition to the Viscaria mine, Copperstone...

April 22, 2022 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that its subsidiary Philips Respironics is notifying customers of its V60/V60 Plus and V680 ventilators about a potential issue with the electrical circuit in these ventilators that controls the 35V power supply to the ventilator and alarm. Philips Respironics has already notified the relevant competent authorities. Philips Respironics has identified that there is a possibility that affected ventilator units may cease to operate, potentially without setting off an audible/visual alarm (a so-called silent shutdown), and the patient may no longer receive respiratory assistance. Philips Respironics projects an average of less than one silent shutdown among one million uses per year. Philips Respironics is...

Company announcement – No. 15 / 2022 Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities Copenhagen, DK and Boston, MA, April 22, 2022 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, announces that it has received information on transactions in Zealand shares or related securities by persons discharging managerial responsibilities. Please see the attached files. # # # About Zealand Pharma A/S Zealand Pharma A/S (Nasdaq: ZEAL) (“Zealand”) is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have...

ENDEAVOUR PROVIDES NOTICE OF SHAREHOLDER MEETING London, 22 April 2022 – Endeavour Mining plc (LSE:EDV, TSX: EDV, OTCQX: EDVMF) (“Endeavour” or the “Group” or the “Company”) has today published notice of its 2022 Annual General Meeting (the “Notice of AGM”), which will be distributed to shareholders shortly. The Company’s AGM will be held on Tuesday 24 May 2022 at 2 pm (London time) / 9 am (Toronto time) at the offices of Linklaters LLP, One Silk Street, London EC2Y 8HQ. A copy of the Notice of AGM is available at www.endeavourmining.com. Shareholders of the Company are encouraged to read the Notice of AGM in full. Shareholders should expect to receive the various meeting materials and forms of proxy by post on or after 22 April 2022. Proxy forms for the AGM must be submitted no later than 2 pm (London time) / 9 am (Toronto time)...

FORT COLLINS, Colo., April 22, 2022 (GLOBE NEWSWIRE) — Mobile Highway Advertising, a dakdan worldwide company announces the addition of Rapid Advanced Multi-Media (RAMM) powered by iSIGN Media Solutions Inc.’s (“iSIGN”) (TSX-V: ISD) (OTC: ISDSF), newest HALO Technology, to generate impressions to mobile devices in proximity to its fleet of brand advertising display trucks and vehicles. This will be the first ever exclusive Mobile Highway Advertising addition to increase and validate advertising impressions to its customers. Mobile Highway Advertising is pleased to be the first mobile vehicle advertiser to add the addition of ubiquitous brand advertising to mobile devices to greatly increase shopper retention and ability to be directed to addition information of each advertised brand. Dan Kost, Mobile Highway Advertising’s CEO is...

The Board of Directors of Lerøy Seafood Group ASA has on 22 April 2022 approved the final financial statements for 2021. The final financial statement, including the proposed dividend payment of NOK 2.5 per share, is in line with the preliminary financial statement published on 17 February 2022. The complete integrated annual report will be published on 29 April 2022. The annual general meeting is scheduled for 23 May 2022. This information is subject to the disclosure requirements pursuant to Section5-12 the Norwegian Securities Trading Act.

In the Phase III IMpower010 trial, adjuvant Tecentriq reduced the risk of disease recurrence or death by 57% in people with PD-L1 high resectable Stage II-III NSCLC compared with best supportive care More than half of people with early-stage NSCLC experience disease recurrence following surgery,1 and most of these recurrent tumours are metastatic, making them incurable2-7 If approved, Tecentriq will be the first and only cancer immunotherapy available for certain people with early-stage NSCLC in EuropeBasel, 22 April 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Tecentriq® (atezolizumab) as an adjuvant treatment, following complete resection and platinum-based chemotherapy, for adults with...

If approved, mosunetuzumab would be the first CD20xCD3 T-cell engaging bispecific antibody available to treat follicular lymphoma (FL) offering a new, off-the-shelf, fixed-duration treatment option The recommendation is based on the GO29781 study where mosunetuzumab induced high complete response rates, with the majority of complete responses lasting for at least 18 months in people with heavily pretreated FLBasel, 22 April 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval under conditional marketing authorisation for mosunetuzumab for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma (FL), who have received at least two prior systemic therapies. Based on this positive...